• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Teva Pharma`s Generics Azilsartan Medoxomil Receives Tentative Approval in US

    FDA

    Zydus Lifesciences gets tentative approval from USFDA for BP lowering drug

    ECONOMIC TIMES

    Zydus Pharms USA Generic Azilsartan Medoxomil Receives Tentative Approval in US

    FDA

    Alkem`s Generic Azilsartan Medoxomil, Chlorthalidone Receives Approval in the U.S.

    FDA

    Lupin receives approval from USFDA for hypertension tablets

    ET HEALTH

    Lupin Ltd Generic Azilsartan Kamedoxomil Receives Approval in the U.S.

    FDA

    FDA Confirms Paragraph IV Patent Litigation for Aprepitant, Azilsartan, Bupivacaine, Cladribine, Elrombopag, Fosnetupitant, Fostamatinib, Ivacaftor and Sodium Thiosulfate.

    FDA

    FDA Confirms Paragraph IV Patent Litigation for Azilsartan Medoxomil and Chlorthalidomide

    FDA

    Lupin receives US FDA approval for generic Edarbi tablets

    PHARMABIZ

    Lupin receives US FDA approval for generic Edarbi tablets

    PHARMABIZ

    FDA Confirms Paragraph IV Patent Challenge of Edarbi 200796(Azilsartan Kamedoxomil) Tablets 40 mg and 80 mg

    FDA

    FDA presents interim limits of nitrosamines in currently marketed ARBs

    FDA

    India’s drug regulatory force conducts third round of raids on manufacturers

    FIERCE PHARMA

    Japanese Companies Make Cautious Return to Indian Pharma Market

    ECONOMIC TIMES

    FDA Provides Generic Approval Roadmap for 38 Drugs, Including Vertex`s Kaldeco

    RAPS

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.